PM385. Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies

Detalles Bibliográficos
Autores principales: Correll, Christoph U., Skuban, Aleksandar, Ouyang, John, Weiller, Emmanuelle, Weiss, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616321/
http://dx.doi.org/10.1093/ijnp/pyw041.385
_version_ 1783266754579922944
author Correll, Christoph U.
Skuban, Aleksandar
Ouyang, John
Weiller, Emmanuelle
Weiss, Catherine
author_facet Correll, Christoph U.
Skuban, Aleksandar
Ouyang, John
Weiller, Emmanuelle
Weiss, Catherine
author_sort Correll, Christoph U.
collection PubMed
description
format Online
Article
Text
id pubmed-5616321
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56163212017-11-27 PM385. Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies Correll, Christoph U. Skuban, Aleksandar Ouyang, John Weiller, Emmanuelle Weiss, Catherine Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616321/ http://dx.doi.org/10.1093/ijnp/pyw041.385 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Correll, Christoph U.
Skuban, Aleksandar
Ouyang, John
Weiller, Emmanuelle
Weiss, Catherine
PM385. Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies
title PM385. Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies
title_full PM385. Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies
title_fullStr PM385. Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies
title_full_unstemmed PM385. Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies
title_short PM385. Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies
title_sort pm385. long-term safety of brexpiprazole (opc-34712) in schizophrenia: results from two 52-week open-label studies
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616321/
http://dx.doi.org/10.1093/ijnp/pyw041.385
work_keys_str_mv AT correllchristophu pm385longtermsafetyofbrexpiprazoleopc34712inschizophreniaresultsfromtwo52weekopenlabelstudies
AT skubanaleksandar pm385longtermsafetyofbrexpiprazoleopc34712inschizophreniaresultsfromtwo52weekopenlabelstudies
AT ouyangjohn pm385longtermsafetyofbrexpiprazoleopc34712inschizophreniaresultsfromtwo52weekopenlabelstudies
AT weilleremmanuelle pm385longtermsafetyofbrexpiprazoleopc34712inschizophreniaresultsfromtwo52weekopenlabelstudies
AT weisscatherine pm385longtermsafetyofbrexpiprazoleopc34712inschizophreniaresultsfromtwo52weekopenlabelstudies

Ejemplares similares